-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenon Pharmaceuticals Q2 EPS $(1.11) Beats $(1.15) Estimate

Benzinga·08/06/2026 20:02:07
Listen to the news
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.11) per share which beat the analyst consensus estimate of $(1.15) by 2.63 percent. This is a 3.74 percent decrease over losses of $(1.07) per share from the same period last year.